Estrogen receptor beta agonists for use in treating mesothelioma

The invention provides a treatment of mesothelioma, especially malignant pleural mesothelioma, using an estrogen receptor subtype (ER ) agonist, wherein the treatment comprises administering the ER agonist to the patient, and then after a time, t, of up to 24 hours; administering a platinum-containi...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	NILSSON, STEFAN, PINTON, GIULIA, MANENTE, ARCANGELA GABRIELLA, MORO, LAURA
Format:	Patent
Sprache:	eng
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The invention provides a treatment of mesothelioma, especially malignant pleural mesothelioma, using an estrogen receptor subtype (ER ) agonist, wherein the treatment comprises administering the ER agonist to the patient, and then after a time, t, of up to 24 hours; administering a platinum-containing anti-cancer drug to the patient. The invention also provides an ER agonist and a platinum-containing anti-cancer drug for use in the treatment of mesothelioma in a patient, wherein the treatment comprises administering the ER agonist to the patient, and then after a time, t, of up to 24 hours, administering the platinum- containing anti-cancer drug to the patient; and a kit comprising a platinum-containing anti- cancer drug and an ER agonist.